Study Details

General Information

Proctor and Gamble Constipation

A Phase II, Randomized, Adaptive Design, Multicenter, Parallel Group, Placebo-controlled, 58-day, Dose-ranging Study of ATI-7505 in Patients with PosChronic Idiopathic Constipation.

Protocol
Identifier2007003
UIDa4a4cd85-db86-4af8-b759-f68bc1c03bc2
StatusDone - Archived
Phase2
CategoryConstipation / Adult
Launch Year2007
NCT Number-
Created2012-05-03 10:54
Last Updated2012-05-03 10:54

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout DateNo
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalZolnouni, ParvanehPZolnouniNo
Recruiter-No
Coordinator-No
Regulatory-No

Custom Fields

No custom fields.

Sponsor & Organization

SponsorProcter & Gamble
DivisionProcter & Gamble
TeamProcter & Gamble
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CRO
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?